• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新城疫病毒融合蛋白F1氨基末端在裂解和融合中的作用

The role of the amino terminus of F1 of the Newcastle disease virus fusion protein in cleavage and fusion.

作者信息

Morrison T, McQuain C, Sergel T, McGinnes L, Reitter J

机构信息

Department of Molecular Genetics and Microbiology, University of Massachusetts Medical School, Worcester 01655.

出版信息

Virology. 1993 Apr;193(2):997-1000. doi: 10.1006/viro.1993.1214.

DOI:10.1006/viro.1993.1214
PMID:8460504
Abstract

Phenylalanine is the amino acid at the amino terminus of the F1 protein of all paramyxovirus fusion proteins with the exception of the avirulent strains of Newcastle disease virus, which have a leucine residue in this position (Toyoda et al. (1989) Virology 169, 273-282). To explore the role of this phenylalanine in the fusion activity of the protein, this residue, amino acid 117 in the fusion protein sequence, was changed to leucine (F117L) or to glycine (F117G) by site-specific mutagenesis while maintaining the cleavage site sequence of virulent strains of NDV. While both wild-type and the F117G protein were proteolytically cleaved and F1 was detected, the F117L protein was not cleaved. In the presence of the HN protein, both wild-type F and F117G proteins stimulated fusion, but the F117L protein was inactive in fusion. However, incubation in trypsin activated the fusion activity of the protein. Thus the phenylalanine at the amino terminus of the F1 component of the fusion protein is not required for the fusion activity of the protein. The presence of a leucine at this position blocks cleavage even though the cleavage site sequence is unchanged.

摘要

除了新城疫病毒无毒株外,所有副粘病毒融合蛋白F1蛋白的氨基末端氨基酸均为苯丙氨酸,新城疫病毒无毒株在该位置有一个亮氨酸残基(丰田等人,(1989年)《病毒学》169,273 - 282)。为了探究该苯丙氨酸在蛋白融合活性中的作用,通过定点诱变将融合蛋白序列中第117位氨基酸残基(即该苯丙氨酸)替换为亮氨酸(F117L)或甘氨酸(F117G),同时保持新城疫病毒强毒株的裂解位点序列。虽然野生型和F117G蛋白都能被蛋白酶裂解并检测到F1,但F117L蛋白未被裂解。在HN蛋白存在的情况下,野生型F蛋白和F117G蛋白都能刺激融合,但F117L蛋白在融合方面无活性。然而,用胰蛋白酶孵育可激活该蛋白的融合活性。因此,融合蛋白F1组分氨基末端的苯丙氨酸对于该蛋白的融合活性并非必需。即使裂解位点序列未改变,该位置存在亮氨酸也会阻止裂解。

相似文献

1
The role of the amino terminus of F1 of the Newcastle disease virus fusion protein in cleavage and fusion.新城疫病毒融合蛋白F1氨基末端在裂解和融合中的作用
Virology. 1993 Apr;193(2):997-1000. doi: 10.1006/viro.1993.1214.
2
[Impact of modification of cleavage site of fusion protein and foreign gene insertion on the virulence of Newcastle Disease Virus LaSota vaccine strain].[融合蛋白切割位点修饰及外源基因插入对新城疫病毒LaSota疫苗株毒力的影响]
Wei Sheng Wu Xue Bao. 2008 Mar;48(3):362-8.
3
Sequence and phylogenetic analysis of the fusion protein cleavage site of Newcastle disease virus field isolates from Iran.伊朗新城疫病毒野毒株融合蛋白裂解位点的序列及系统发育分析
Acta Virol. 2002;46(4):247-51.
4
Effect of host selective pressure on Newcastle disease virus virulence.宿主选择压力对新城疫病毒毒力的影响。
Microb Pathog. 2008 Feb;44(2):135-40. doi: 10.1016/j.micpath.2007.08.012. Epub 2007 Aug 25.
5
Mutational analysis of the membrane proximal heptad repeat of the newcastle disease virus fusion protein.新城疫病毒融合蛋白膜近端七肽重复序列的突变分析
Virology. 2001 Oct 25;289(2):343-52. doi: 10.1006/viro.2001.1123.
6
The attachment function of the Newcastle disease virus hemagglutinin-neuraminidase protein can be separated from fusion promotion by mutation.新城疫病毒血凝素-神经氨酸酶蛋白的附着功能可通过突变与融合促进作用分离。
Virology. 1993 Apr;193(2):717-26. doi: 10.1006/viro.1993.1180.
7
The fusion promotion activity of the NDV HN protein does not correlate with neuraminidase activity.新城疫病毒血凝素-神经氨酸酶(NDV HN)蛋白的融合促进活性与神经氨酸酶活性无关。
Virology. 1993 Oct;196(2):831-4. doi: 10.1006/viro.1993.1541.
8
Nucleotide sequence of the fusion and haemagglutinin-neuraminidase glycoprotein genes of Newcastle disease virus, strain Ulster: molecular basis for variations in pathogenicity between strains.新城疫病毒乌尔斯特株融合蛋白基因和血凝素-神经氨酸酶糖蛋白基因的核苷酸序列:毒株间致病性差异的分子基础
J Gen Virol. 1988 Mar;69 ( Pt 3):613-20. doi: 10.1099/0022-1317-69-3-613.
9
Carbohydrate modifications of the NDV fusion protein heptad repeat domains influence maturation and fusion activity.新城疫病毒融合蛋白七肽重复结构域的碳水化合物修饰影响成熟和融合活性。
Virology. 2001 May 10;283(2):332-42. doi: 10.1006/viro.2001.0899.
10
The pathogenesis of Newcastle disease: a comparison of selected Newcastle disease virus wild-type strains and their infectious clones.新城疫的发病机制:选定的新城疫病毒野生型毒株及其感染性克隆的比较。
Virology. 2006 Sep 30;353(2):333-43. doi: 10.1016/j.virol.2006.06.013. Epub 2006 Jul 24.

引用本文的文献

1
Molecular characterization of full fusion protein (F) of Newcastle disease virus genotype VIId isolated from Egypt during 2012-2016.2012年至2016年期间从埃及分离的新城疫病毒VII d基因型全融合蛋白(F)的分子特征
Vet World. 2018 Jul;11(7):930-938. doi: 10.14202/vetworld.2018.930-938. Epub 2018 Jul 15.
2
Antitumor and immunostimulatory activities of a genotype V recombinant attenuated veterinary Newcastle disease virus vaccine.基因型V重组减毒兽用新城疫病毒疫苗的抗肿瘤和免疫刺激活性
Oncol Lett. 2018 Jan;15(1):1246-1254. doi: 10.3892/ol.2017.7387. Epub 2017 Nov 9.
3
Two mutations in the HR2 region of Newcastle disease virus fusion protein with a cleavage motif "RRQRRL" are critical for fusogenic activity.
新城疫病毒融合蛋白 HR2 区的两个具有“RRQRRL”切割基序的突变对于融合活性至关重要。
Virol J. 2017 Sep 25;14(1):185. doi: 10.1186/s12985-017-0851-0.
4
Recombinant lentogenic Newcastle disease virus expressing Ebola virus GP infects cells independently of exogenous trypsin and uses macropinocytosis as the major pathway for cell entry.表达埃博拉病毒 GP 的重组低致病性新城疫病毒可独立于外源性胰酶感染细胞,并利用巨胞饮作用作为主要的细胞进入途径。
Virol J. 2013 Nov 9;10:331. doi: 10.1186/1743-422X-10-331.
5
High genetic diversity of Newcastle disease virus in poultry in West and Central Africa: cocirculation of genotype XIV and newly defined genotypes XVII and XVIII.西非和中非家禽中新城疫病毒的高遗传多样性:基因型 XIV 和新定义的基因型 XVII 和 XVIII 的共同流行。
J Clin Microbiol. 2013 Jul;51(7):2250-60. doi: 10.1128/JCM.00684-13. Epub 2013 May 8.
6
Prostate-specific antigen-retargeted recombinant newcastle disease virus for prostate cancer virotherapy.靶向前列腺特异性抗原的重组新城疫病毒用于前列腺癌的病毒治疗。
J Virol. 2013 Apr;87(7):3792-800. doi: 10.1128/JVI.02394-12. Epub 2013 Jan 23.
7
Generation by reverse genetics of an effective, stable, live-attenuated newcastle disease virus vaccine based on a currently circulating, highly virulent Indonesian strain.利用反向遗传学技术,基于当前流行的高致病性印度尼西亚毒株,生成一种有效、稳定、减毒的新型鸡瘟活疫苗。
PLoS One. 2012;7(12):e52751. doi: 10.1371/journal.pone.0052751. Epub 2012 Dec 21.
8
Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions.溶瘤性新城疫病毒在癌症治疗中的应用:旧挑战与新方向。
Future Microbiol. 2012 Mar;7(3):347-67. doi: 10.2217/fmb.12.4.
9
Mutation of the f-protein cleavage site of avian paramyxovirus type 7 results in furin cleavage, fusion promotion, and increased replication in vitro but not increased replication, tissue tropism, or virulence in chickens.禽类副黏病毒 7 型 f 蛋白裂解位点突变导致弗林蛋白酶裂解、融合促进以及体外复制增加,但不导致在鸡中的复制增加、组织嗜性或毒力增强。
J Virol. 2012 Apr;86(7):3828-38. doi: 10.1128/JVI.06765-11. Epub 2012 Jan 18.
10
Identification and complete genome sequencing of paramyxoviruses in mallard ducks (Anas platyrhynchos) using random access amplification and next generation sequencing technologies.利用随机扩增多态性 DNA 技术和下一代测序技术鉴定和测序野鸭(Anas platyrhynchos)中的副黏病毒。
Virol J. 2011 Oct 6;8:463. doi: 10.1186/1743-422X-8-463.